Page last updated: 2024-11-02

oxymetazoline and Alloxan Diabetes

oxymetazoline has been researched along with Alloxan Diabetes in 3 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakadate, T1
Nakaki, T1
Yamamoto, S1
Kato, R1
Yamatani, K1
Marubashi, S1
Wakasugi, K1
Saito, K1
Sato, N1
Takahashi, K1
Sasaki, H1
Drukarch, B1
Schepens, E1
Heimans, JJ1
Stoof, JC1

Other Studies

3 other studies available for oxymetazoline and Alloxan Diabetes

ArticleYear
Protection against alloxan-induced diabetes in mice by stimulation of alpha 2-adrenergic receptors.
    Life sciences, 1983, Feb-14, Volume: 32, Issue:7

    Topics: Adrenergic alpha-Agonists; Alloxan; Animals; Clonidine; Diabetes Mellitus, Experimental; Epinephrine

1983
Catecholamine-induced cAMP response in streptozotocin-induced diabetic rat liver.
    The Tohoku journal of experimental medicine, 1994, Volume: 173, Issue:3

    Topics: Adipose Tissue; Animals; Colforsin; Cyclic AMP; Diabetes Mellitus, Experimental; Emaciation; Epineph

1994
Alpha 2-adrenoceptor-mediated modulation of noradrenaline release is decreased in vas deferens but not in cerebral cortex of diabetic rats.
    Journal of the neurological sciences, 1989, Volume: 91, Issue:3

    Topics: Animals; Cerebral Cortex; Diabetes Mellitus, Experimental; Electric Stimulation; In Vitro Techniques

1989